Not so funny if they have an inside man feeding them what is being submitted.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-975
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.8¢ |
Change
-0.013(1.29%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $2.114M | 2.190M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 71509 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 81918 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
41 | 67669 | 0.955 |
22 | 161251 | 0.950 |
20 | 240631 | 0.945 |
14 | 229646 | 0.940 |
13 | 339516 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 81641 | 25 |
0.965 | 179357 | 25 |
0.970 | 177020 | 15 |
0.975 | 128486 | 9 |
0.980 | 242173 | 10 |
Last trade - 14.51pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online